Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide

Lumican is a small leucine-rich proteoglycan (SLRP) being known as a key regulator of collagen fibrillogenesis. However, little attention has been given so far in studying its influence on tumor-associated matrix architecture. Here, we investigate the role of host lumican on tumor matrix organizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeanne, Albin, Untereiner, Valérie, Perreau, Corinne, Proult, Isabelle, Gobinet, Cyril, Boulagnon-Rombi, Camille, Terryn, Christine, Martiny, Laurent, Brézillon, Stéphane, Dedieu, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550434/
https://www.ncbi.nlm.nih.gov/pubmed/28794454
http://dx.doi.org/10.1038/s41598-017-07043-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550434/
https://www.ncbi.nlm.nih.gov/pubmed/28794454
http://dx.doi.org/10.1038/s41598-017-07043-9

Ejemplares similares